SAS | The Power to Know
White Paper

Argyle Conversations: Marketing analytics helps Pfizer deliver healthy value propositions

The importance of creating and articulating a value proposition that serves both businesses and consumers

About this paper

It used to be that having a good product or a new mechanism in the pharmaceutical industry gave you a reasonable amount of market success. Today, things are very different. This Argyle Conversations paper features an interview between Robert Besthof, Vice President of Commercial Development, Neuroscience and Pain, at Pfizer, and Christian Nimsch, Head of the Center for Health Analytics and Insights at SAS, about the evolving role of marketing in the pharmaceutical industry and how critical a role marketing analytics plays today in creating and articulating a value proposition that serves both businesses and consumers. Read this paper to learn more about the steps Pfizer takes to successfully develop value propositions for its products.

About SAS

SAS is the leader in analytics. Through innovative analytics, business intelligence and data management software and services, SAS helps customers at more than 83,000 sites make better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.

Вы уже заполняли профиль SAS? Войдите, чтобы заполнить поля автоматически Войти

  Да, я хочу периодически получать электронные письма от SAS Institute Inc. и ее подразделений о продуктах и услугах SAS. Я понимаю, что я могу отозвать свое согласие в любое время, нажав на ссылку «Отписаться от рассылки» в email-сообщениях.

All personal information will be handled in accordance with the SAS Privacy Statement.


Back to Top